BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 16820567)

  • 1. Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis.
    Cullen ME; Yuen AH; Felkin LE; Smolenski RT; Hall JL; Grindle S; Miller LW; Birks EJ; Yacoub MH; Barton PJ
    Circulation; 2006 Jul; 114(1 Suppl):I16-20. PubMed ID: 16820567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy.
    Barton PJ; Felkin LE; Birks EJ; Cullen ME; Banner NR; Grindle S; Hall JL; Miller LW; Yacoub MH
    Circulation; 2005 Aug; 112(9 Suppl):I46-50. PubMed ID: 16159864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of extracellular matrix genes during myocardial recovery from heart failure after left ventricular assist device support.
    Felkin LE; Lara-Pezzi E; George R; Yacoub MH; Birks EJ; Barton PJ
    J Heart Lung Transplant; 2009 Feb; 28(2):117-22. PubMed ID: 19201335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support.
    Birks EJ; Hall JL; Barton PJ; Grindle S; Latif N; Hardy JP; Rider JE; Banner NR; Khaghani A; Miller LW; Yacoub MH
    Circulation; 2005 Aug; 112(9 Suppl):I57-64. PubMed ID: 16159866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy.
    Hall JL; Birks EJ; Grindle S; Cullen ME; Barton PJ; Rider JE; Lee S; Harwalker S; Mariash A; Adhikari N; Charles NJ; Felkin LE; Polster S; George RS; Miller LW; Yacoub MH
    Eur Heart J; 2007 Mar; 28(5):613-27. PubMed ID: 17132651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term mechanical unloading and reverse remodeling of failing hearts in children.
    Mohapatra B; Vick GW; Fraser CD; Clunie SK; Towbin JA; Sinagra G; Vatta M
    J Heart Lung Transplant; 2010 Jan; 29(1):98-104. PubMed ID: 19783184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
    Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
    J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of stem cell factor and its receptor after left ventricular assist device support: a potential novel target for therapeutic interventions in heart failure.
    Jahanyar J; Youker KA; Torre-Amione G; Koerner MM; Bruckner B; Noon GP; Loebe M
    J Heart Lung Transplant; 2008 Jul; 27(7):701-9. PubMed ID: 18582797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
    Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
    J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in sarcomeric and non-sarcomeric cytoskeletal proteins and focal adhesion molecules during clinical myocardial recovery after left ventricular assist device support.
    Latif N; Yacoub MH; George R; Barton PJ; Birks EJ
    J Heart Lung Transplant; 2007 Mar; 26(3):230-5. PubMed ID: 17346624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in regulatory microRNA expression in myocardium of heart failure patients on left ventricular assist device support.
    Schipper ME; van Kuik J; de Jonge N; Dullens HF; de Weger RA
    J Heart Lung Transplant; 2008 Dec; 27(12):1282-5. PubMed ID: 19059107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
    Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA
    J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a gene expression profile that differentiates between ischemic and nonischemic cardiomyopathy.
    Kittleson MM; Ye SQ; Irizarry RA; Minhas KM; Edness G; Conte JV; Parmigiani G; Miller LW; Chen Y; Hall JL; Garcia JG; Hare JM
    Circulation; 2004 Nov; 110(22):3444-51. PubMed ID: 15557369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the global mRNA expression profile of human atrial and ventricular myocardium with high-density oligonucleotide arrays.
    Ellinghaus P; Scheubel RJ; Dobrev D; Ravens U; Holtz J; Huetter J; Nielsch U; Morawietz H
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1383-90. PubMed ID: 15942582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNFalpha in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device.
    Bruggink AH; van Oosterhout MF; De Jonge N; Gmelig-Meyling FH; De Weger RA
    Transpl Immunol; 2008 Apr; 19(1):64-8. PubMed ID: 18346639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern.
    Bruggink AH; van Oosterhout MF; de Jonge N; Ivangh B; van Kuik J; Voorbij RH; Cleutjens JP; Gmelig-Meyling FH; de Weger RA
    J Heart Lung Transplant; 2006 Sep; 25(9):1091-8. PubMed ID: 16962471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global gene expression analysis in nonfailing and failing myocardium pre- and postpulsatile and nonpulsatile ventricular assist device support.
    Schwientek P; Ellinghaus P; Steppan S; D'Urso D; Seewald M; Kassner A; Cebulla R; Schulte-Eistrup S; Morshuis M; Röfe D; El Banayosy A; Körfer R; Milting H
    Physiol Genomics; 2010 Aug; 42(3):397-405. PubMed ID: 20460602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The slow skeletal muscle troponin T gene is expressed in developing and diseased human heart.
    Barton PJ; Felkin LE; Koban MU; Cullen ME; Brand NJ; Dhoot GK
    Mol Cell Biochem; 2004 Aug; 263(1-2):91-7. PubMed ID: 15524170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process.
    Klotz S; Jan Danser AH; Burkhoff D
    Prog Biophys Mol Biol; 2008; 97(2-3):479-96. PubMed ID: 18394685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.